Willow Biosciences Inc WLLW

TOR: WLLW | ISIN: CA97111B4047 31/05/2024

0,130 CAD (+23,81%)

(+23,81%) 31/05/2024

Grafiek Willow Biosciences Inc

Grafiek Willow Biosciences Inc

1 dag1d 23,81%
1 week1w 62,50%
1 maand1m 52,94%
3 maanden3m 13,04%
6 maanden6m 30,00%
1 jaar1j 4,00%
5 jaar5j -77,59%

Willow Biosciences Inc in het nieuws

Toon enkel gratis nieuws

30 mei 2024 · Willow Announces Multi-Product Development And Licensing Partnership With Laurus Labs For Manufacturing Active Pharmaceutical Ingredients · Persbericht

13 mei 2024 · Willow Biosciences Reports First Quarter 2024 Financial Results And Provides Corporate Update · Persbericht

29 maart 2024 · Willow Biosciences Reports Fourth Quarter And Fiscal Year 2023 Financials And Operations And Filing Of Its 2023 Aif · Persbericht

1 maart 2024 · Willow Biosciences Announces Second Strategic Investment From Kalsec · Persbericht

21 februari 2024 · Willow Biosciences Announces Strategic Investment From Kalsec To Develop Innovative Natural Food Ingredients · Persbericht

31 januari 2024 · Willow Announces Collaboration With Global Ingredient Manufacturer To Develop A More Cost-Effective, Sustainable Process For A Large Volume Active Pharmaceutical Ingredient · Persbericht

16 januari 2024 · Willow Announces Collaboration With Enterin To Develop Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

10 januari 2024 · Willow Plans For Significant Growth In 2024 On The Back Of A Successful 2023 · Persbericht

7 december 2023 · Willow And Leading Innovative Biopharmaceutical Company Advance Development Program To Manufacture Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

11 oktober 2023 · Willow Biosciences Announces Completion Of Previously Announced Convertible Debenture Financing · Persbericht

Profiel Willow Biosciences Inc

Commerciële diensten

Diverse commerciële diensten

Mijnbouw, steenhouwerij en olie- en gaswinning

Winning van edelstenen en delfstoffen

CEO: Trevor Peters

Aandelen Willow Biosciences Inc

Beurswaarde: 16,54 miljoen CAD

Effecten: 127,22 miljoen

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe